CD40 is a 50 kDa molecule, a member of the tumor necrosis factor/nerve growth factor receptor family. It is expressed on B cells, monocytes, dendritic cells and various malignant cells. While the critical relevance of this molecule in T cell-dependent B cell activation is already established, the biological role of CD40-CD154 interaction in non-hematopoietic cells is still unknown. Here we show that CD40 is functionally expressed on human melanoma-derived cell lines. No correlation between surface CD40 expression and the origin of the cell line, primary versus metastatic, was observed. Melanoma cells were shown to be able to co-stimulate TCR-triggered human T cells; moreover, because they do not express CD80 or CD86 co-stimulatory structures, the involvement of additional pathways have to be postulated. We have identified CD40 as one of the molecules involved in melanoma cell-mediated co-stimulation of anti-CD3-triggered human CD4 ⍣ T lymphocytes. In addition, a CD40-dependent pathway, able to enhance tumor cell proliferation at low serum concentrations, in vitro, has been shown to be functional in human melanoma cell lines.
Introduction
T cell activation requires both a specific signal delivered by (9). On the other hand, persistence and progressive growth of tumors indicate that the immune system is not generally antigenic peptide-MHC complexes to TCR molecules and a second signal, mediated by surface co-stimulatory molecules competent to control the malignancy. In this context, a failure in co-stimulation has been suggested as a relevant escape (1). TCR signaling in the absence of co-stimulation usually results in T cell inactivation or anergy, which is associated with mechanism for tumor cells from immune rejection (10). CD40 is a 50 kDa membrane glycoprotein expressed on B a block in IL-2 gene transcription (2). Unlike TCR signaling, the delivery of co-stimulatory signals is neither antigen specific cells (11), dendritic cells (12) and monocytes (13), involved in functional interactions between B and T lymphocytes (14). nor MHC restricted. One important co-stimulatory signal is transduced in T cells by the CD28-CTLA-4-dependent This molecule is a member of the tumor necrosis factor/nerve growth factor receptor family (15) which includes molecules pathway (2). Although transfection experiments clearly demonstrate that the CD28 receptor-ligand system can be like CD27 (16) , CD30 (17) and CD95 (18) antigen, all of them critical for the regulation of both proliferation and apoptosis both necessary and sufficient for T cell co-stimulation, costimulatory pathways, virtually distinct from such ligandof hematopoietic cells (15) . Murine and human forms of a ligand for CD40, induced on T cells following activation, were receptor pairs, were described (3-7).
Several studies seem to indicate that tumor cells are able cloned and found to be a membrane glycoprotein, CD154, with a mol. wt~39 kDa (19, 20) . Also, mast cells (21) , eosinoto deliver antigen-specific signals to T lymphocytes (8). In addition, a limited anti-tumor response has been demonphils (22) and B cells (23) can be induced to express a functional CD154. Mutations in the CD154 cause an hyperstrated by the identification of tumor-reactive cytotoxic T lymphocytes (CTL) from peripheral blood of cancer patients IgM immunodeficiency in humans (24) , demonstrating the importance of the CD40 molecule-mediated interactions in B mouse Ig (Dynal, Oslo, Norway) and a samarium cobalt magnet. The depletion procedure was repeated twice. Less cell maturation. On the other hand, CD40-dependent pathways were observed to orchestrate the response of regulatory than 2% of the remaining cells expressed the antigen for which they were depleted, as assessed by immunofluorescence and T cells both during their development (25, 26) and their encounter with the antigen (6,14,27,28).
FACS analysis. Functional expression of CD40 has been already described mAb, immunofluorescence and flow cytometry on a wide range of non-hematopoietic cell types, but the The anti-CD3 mAb CLB-CD3/4E (IgE) (43) and the anti-CD40 biological significance of CD40-CD154 interaction in normal inducer mAb 14G7 (IgM) (44) were a gift of Dr R. van as well as in transformed non-hematopoietic cells is still Lier (Central Laboratory of the Blood Transfusion Service, undefined. Thymic epithelial cells (29) , keratinocytes (30) , Amsterdam, The Netherlands), whereas the control mAb fibroblasts derived from the lung, gingiva, synovium and VF20-VT43 (IgG2a) and KS5 (IgM) were a generous gift of dermis (31) , and vascular endothelial cells (32) were shown Dr S. Ferrone (Roswell Park Cancer Institute, Buffalo, NY). to express CD40 molecule. This antigen was also observed
The anti-CD40 mAb 89 and 3C6 (both IgG1), and the on a variety of tumors including nasopharingeal (33) , bladder, anti-CD154 mAb TRAP-1 (IgG1) were purchased from breast and colon carcinoma (34) (35) (36) ; moreover, human melanBeckman-Coulter (Fullerton, CA) and PharMingen (San Diego, oma cells were also described to express the CD40 molec-CA) respectively. FITC-and phycoerythrin-labeled mAb ule (37, 38 mAb (IgG1) and anti-low-molecular-weight melanomaIn this study we investigated whether the CD40 molecule, associated-antigen (LMW-MAA) HMB45 mAb (IgG1), both a functionally expressed on human melanoma cell lines, could generous gift of Dr S. Ferrone, were used. In addition, FITCact as a co-stimulatory structure in the presence of TCR labeled anti-CD54, 6.5B5 mAb (IgG1) purchased from Dako triggering. The role of CD40-dependent pathways in tumor Italia (Milan, Italy) and anti-CD44, G44-26 mAb (IgG2b) cell proliferation has been also analyzed.
obtained from PharMingen were employed. Flow cytometry and data analysis were performed by using a Becton
Methods
Dickinson FACS Vantage flow cytometer and CellQuest analysis software, as described (45) .
Melanoma lines and T lymphocyte populations
Proliferation assay Cultures of human melanoma cells were established as Melanoma cells (5ϫ10 4 ) were cultured in 24-well microtiter reported (41). In brief, tumor tissue, suspended in DMEM plates (Falcon, Seattle, WA) in the presence of DMEM concontaining 20% FCS and supplemented with penicillintaining different percentages of FCS, as indicated in Results. streptomycin (100 IU/ml and 100 µg/ml), gentamycin Human rIFN-γ was purchased from Sigma-Aldrich Italia. (80 µg/ml) and L-glutamine (all purchased from Gibco, Paisley, Resting peripheral T cells (2ϫ10 5 ) were activated with anti-UK), was minced with scalpels to a fine suspension which CD3 mAb CLB-CD3/4E, in 96-well flat-bottomed microtiter was repeatedly pipetted and centrifuged at 180 g for 5 min plates (Falcon, Seattle, WA) in the presence of different at room temperature. Cells were then re-suspended in fresh percentages of 100 Gy irradiated melanoma cells, as indicomplete medium and cultured in six-well microtiter plates cated in Results. (Falcon, Seattle, WA) at 37°C in a humidified incubator with Cultures were incubated for 3 days at 37°C in a humidified 5% CO 2 .
atmosphere containing 5% CO 2 and pulsed with 0.5 µCi/well T lymphocytes were isolated from peripheral venous [ 3 H]thymidine for the final 16 h. The incorporation of labeled samples obtained from normal healthy donors, as previously nucleotide was determined by scintillation counting, after described (42). Briefly, small, resting T lymphocytes were harvesting, using an automatic cell harvester. All tests were purified by using a Percoll density gradient after removal of performed in the presence of RPMI 1640 medium supple-B cells and monocytes by plastic and nylon wool adherence.
mented with 5% heat-inactivated FCS. The recovered high buoyant density population was always Statistical analysis of data was performed using Student's Ͼ97% CD3 ϩ , CD56 -. The purity of T cell preparations was t-test. assessed by using immunofluorescence and phytohemagglutinin stimulation. To prepare CD4 ϩ and CD8 ϩ subpopulations, T cells, purified as described, were incubated with Results saturating concentrations of anti-CD4 or anti-CD8 mAb
Human melanoma cells express a functional CD40 molecule obtained from OKT4 and OKT8 hybridomas (both IgG2a), provided by ATCC (Rockville, MD). The labeled cells were CD40 expression has been described on human melanoma cells (36, 37) . To examine whether CD40-CD154 binding might removed by using magnetic beads coated with sheep anti- ascites. This mAb can stimulate purified peripheral blood Because pro-inflammatory mediators had been already T cells in the absence of cross-linking (43). The involvement described to up-regulate CD40 surface levels (46), we investiof a CD40-mediated pathway in the co-stimulation of TCRgated the possibility that IFN-γ treatment could affect CD40 dependent T cell proliferation has already been described by expression also on melanoma cells. Figure 1 shows that 48 us and others (6,25). To investigate whether CD40 might h incubation of CD40 ϩ melanoma cell lines in the presence play a role in melanoma-mediated co-stimulation of CD3-of rIFN-γ, at 250 IU/ml, significantly up-regulates CD40 surface dependent T cell proliferation, the cultures were performed levels. No CD40 induction on CD40 -melanoma cell lines was in the presence of saturating concentrations of anti-CD40 observed. Time and doses of rIFN-γ treatment were defined mAb 89 or of the control mAb VF20-VT43. in preliminary experiments.
As shown in Fig. 3 , CD40 ϩ melanoma cell lines were able CD40-CD154 interaction was demonstrated to up-regulate to co-stimulate TCR-triggered human T cells. Figure 3 (A) adhesion molecules on fibroblasts (47) and B cells (48), as well clearly shows that Ͻ5% of irradiated CD40 ϩ melanoma cells as CD80, CD86, CD58 and MHC class II antigen expression on was enough to obtain an optimal co-stimulation. In addition, B cells and monocytes (48). An effect on CD95 expression Fig. 3(B) shows that the presence of anti-CD40 mAb 89, but on B lymphocytes was also observed (49). Therefore, we not of the control mAb, significantly affected the ability of the investigated whether CD40 triggering could affect the expres-CD40 ϩ melanoma cells to co-stimulate TCR-triggered resting sion of such molecules also on CD40 ϩ melanoma cell lines.
T cells (P Ͻ 0.004). An inhibition rate ranging from 35 to 65%, In this effort we used both the Jurkat-derived subclone J39.9, as evaluated in five independent experiments, was observed. already described by us as constitutively expressing the Intriguingly, CD40 -melanoma cell lines were also able to CD154 molecule (25) and the control CD154 -Jurkat subclone co-stimulate TCR-triggered T cells, even though at lower WT.6. Figure 2(A) shows that overnight incubation of CD40 ϩ efficiency (P Ͻ 0.02), as compared with the CD40 ϩ countermelanoma cells in the presence of the X-ray irradiated CD154 ϩ part (Fig. 3C) . Jurkat subclone J39.9, but not of the CD154 -subclone WT.6, CD40 was described to preferentially co-stimulate TCRwas able to significantly up-regulate the CD54 molecule triggered CD4 ϩ human T cells (6,25). Therefore, we performed expression. The effect was completely inhibited by using experiments in which purified CD4 ϩ or CD8 ϩ T cells were J39.9 cells pre-treated with anti-CD154 mAb or anti-CD40 tested for their ability to be co-stimulated by CD40-expressing mAb (Fig. 2B) . No effect was observed on CD80, CD86, melanoma cells. As shown in Fig. 4 , CD40 ϩ melanoma cells CD95 or MHC class II expression, whereas a slight increase were able to co-stimulate both CD4 ϩ and CD8 ϩ human T in CD58 (LFA-3) membrane levels was also observed (not cells, whereas anti-CD40 mAb was observed to significantly shown). Similar results were obtained by using as triggering element the anti-CD40 inducer mAb 14G7 (data not shown).
affect only CD4 ϩ T cell proliferation (P Ͻ 0.006). Interestingly, CD40 -melanoma cell lines maintained their ability to coderived cell lines as compared to the CD40 -counterpart (not shown). Interestingly, as shown in Fig. 5 , in each experimental stimulate, even if at a lower extent, both CD4 ϩ as well as CD8 ϩ T lymphocytes (not shown).
condition the presence of the anti-CD40 inducer mAb 14G7 significantly enhanced (P Ͻ 0.01) the proliferation of CD40 ϩ These results indicate that CD40 antigen expressed by melanoma cells might play a role in the co-stimulation of melanoma cells. No interference was observed in the presence of the control mAb KS5. The effect appeared to be TCR-triggered CD4 ϩ , but not of CD8 ϩ human T cells; this observation, the inability to show evidence of CD80 or CD86 more relevant in the presence of low serum concentrations. Also in the absence of serum, CD40 triggering was able to antigens on melanoma-derived cell lines and the maintained co-stimulatory ability of CD40 -melanoma cells, suggest the induce a significant increase in melanoma cell proliferation levels (Fig. 5C ). As shown in Fig. 5(D) , anti-CD40 treatment involvement of additional co-stimulatory pathways.
was unable to affect the proliferation levels of CD40 -melan-CD40 triggering is able to significantly increase melanoma oma cell lines at all serum concentrations.
cell proliferation at low serum concentrations
Our results show that a CD40-mediated pathway could be involved in melanoma cell proliferation, especially when 'nonOur data demonstrate that CD40-dependent intracellular pathways are functional in melanoma cells, being able to significoptimal' culture conditions were employed. The CD40 molecule therefore might act both as a co-stimulatory structure antly modify the surface phenotype of tumor cells (Fig. 2) . Therefore, we analyzed whether CD40-dependent signals involved in TCR-dependent T cell proliferation and as a signaling element which plays a critical role in the regulation of could also affect the growth rate of cultured melanoma cells. The anti-CD40 14G7 mAb was used as a CD40-specific melanoma cell growth. Serum lacking and probably stressing conditions seem to potentiate such effect in vitro. triggering element. Proliferation levels were measured by using a classic thymidine incorporation assay after a 48 h incubation period performed in the presence of different serum Discussion concentrations. Melanoma cells, cultured in the presence of decreasing percentages of serum, also revealed decreasing CD40-CD154-mediated interactions not only are important in the regulation of the adaptive immune response, but are also proliferation levels. In this context no differences were observed in the proliferation levels of the CD40 ϩ melanomainvolved in the inflammatory response, the regulation of CD80 or CD86, the co-stimulatory signals should be provided critical role of CD40-dependent pathways in the regulation of both the innate (50, 56) as well as adaptive (46,50) immune by other molecules. This study identifies CD40 as one of the molecules involved in melanoma cell-mediated co-stimulation response suggests that we should investigate the potential ability of CD40 antigen to provide a useful frame for the of anti-CD3-induced human T cell proliferation. In addition, the preferential role of this molecule in delivering accessory establishment of an effective anti-tumor immune response. Therefore, the analysis of the biological mechanisms undersignals to CD4 ϩ T lymphocytes (6,26) was confirmed.
Recent data (52) show a lack of immune response to lying the complex balance between CD40-dependent immune co-stimulation and tumor survival could provide novel tools autologous tumors in CD154-deficient mice, strongly reinforcing the central role of the CD40-CD154 pathway in T cell for innovative immune therapeutic approaches. priming. It is not clear if CD40-CD154 interaction could also affect the priming of CD8 ϩ T cells, but the observation that Acknowledgments the antiviral CD8-dependent CTL memory responses appear and still controversial appears to be the available data on the 
